Table 1. Clinical and Biochemical Characteristics of T2DM Subjects Compared with Control Subjects.
| Control (n = 34) | T2DM (n = 30) | P value | |
| Age, yrs | 38.9±12.4 | 51.3±12.6 | 0.00021 |
| BMI, kg/m2 | 26.5±4.4 | 37.2±9.0 | <0.0001 |
| Sex (M∶F) | 12∶22 | 24∶6 | NA |
| Visfatin, log ng/mL | 11.39 (9.64, 18.97 ) | 23.01 (11.77, 28.28) | 0.008 |
| Insulin, (median IU/mL (min, max) | 11.4 (2.8, 18.1) | 11.5 (3.5, 25.7) | N/S |
| Glucose mmol/L | 5.47±0.77 | 8.36±2.66 | 0.0009 |
| HOMA-IR | 2.91±1.53 | 4.16±1.68 | 0.043 |
| TNF-α, pg/mL | 11.11±3.28 | 16.9±16.5 | 0.00038 |
| IL-6, pg/mL | 4.61±2.32 | 7.03±2.42 | 0.00014 |
| sCD14, million IU/mL | 1.45±0.40 | 2.8±1.01 | <0.0001 |
| Leptin, log pg/mL | 15.68 (5.89, 33.79) | 22.79 (12.18, 45.72) | N/S |
Data are presented as mean (±SD), unless otherwise stated. Non-parametric data have been log transformed in which case they are presented as mean (interquartile range).